Zihai Ding
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zihai Ding has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Bingquan Lin
Department of Imaging Center, NanFang Hospital of Southern Medical University, No. 1838 Guangzhou Ave North, Baiyun District, Guangzhou 510515, China
1 shared publicationCong Xu
Department of Orthopaedics, The Fourth Affiliated Hospital of Nanchang University, No. 133 square south road, Xihu District, Nanchang 330003, China
1 shared publicationDonghui Zhao
Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China
1 shared publicationJunna Ge
Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China
1 shared publication- Shangtong Lei
Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China
1 shared publication - Shijie Huang
Sichuan Jiaotong Polytechnic University
1 shared publication
Latest Publications
- Open Access
- 25 October 2016
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 5 (6) , 731-739
Experience in clinical diagnosis and treatment of duodenal tumors
Small bowel tumors are rare tumors. Duodenal tumors occur more commonly compared with other small intestinal tumors. To summarize the clinicopathological features of duodenal tumors, in the present study 44 cases of duodenal tumors were collected, and the comparative clinicopathological characteristics between tumors of the ampulla and non‑ampulla, the choice of treatment, and differences in the prognosis, were analyzed. The pathological type identified was predominantly adenocarcinoma; periampullary duodenal tumors were almost classifiable as adenocarcinoma in terms of their type. Non‑ampulla duodenal tumors also included rare pathological types, such as stromal tumor and large B‑cell lymphoma. The symptoms of duodenal tumors were non‑specific, therefore rendering early diagnosis and treatment difficult. Due to jaundice, periampullary duodenal tumors were diagnosed earlier than non‑ampulla duodenal tumors. Endoscopy and computed tomography (CT) examinations were valuable in terms of diagnosis, and were used as a means of screening. Carcinoembryonic antigen (CEA) and cancer antigen 199 (CA199) were revealed to be important as biomarkers. Radical surgery was the most effective treatment. Pancreaticoduodenectomy was revealed to be applicable in all cases of duodenal tumors. For non‑ampulla duodenal tumors, partial duodenum resection and subtotal gastrectomy were appropriate for selection as methods of treatment. No survival benefits were identified for adjuvant chemotherapy. Duodenal tumors were shown to be a rare neoplasm with atypical symptoms; they should be diagnosed and treated as early as possible; CT and gastroscopy may be used for screening, radical surgery offers the best treatment; pancreatoduodenectomy is not the only surgery option available; and chemotherapy did not result in any survival benefits.
- 25 October 2016
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 5 (6) , 731-739
Open AccessExperience in clinical diagnosis and treatment of duodenal tumors
Small bowel tumors are rare tumors. Duodenal tumors occur more commonly compared with other small intestinal tumors. To summarize the clinicopathological features of duodenal tumors, in the present study 44 cases of duodenal tumors were collected, and the comparative clinicopathological characteristics between tumors of the ampulla and non‑ampulla, the choice of treatment, and differences in the prognosis, were analyzed. The pathological type identified was predominantly adenocarcinoma; periampullary duodenal tumors were almost classifiable as adenocarcinoma in terms of their type. Non‑ampulla duodenal tumors also included rare pathological types, such as stromal tumor and large B‑cell lymphoma. The symptoms of duodenal tumors were non‑specific, therefore rendering early diagnosis and treatment difficult. Due to jaundice, periampullary duodenal tumors were diagnosed earlier than non‑ampulla duodenal tumors. Endoscopy and computed tomography (CT) examinations were valuable in terms of diagnosis, and were used as a means of screening. Carcinoembryonic antigen (CEA) and cancer antigen 199 (CA199) were revealed to be important as biomarkers. Radical surgery was the most effective treatment. Pancreaticoduodenectomy was revealed to be applicable in all cases of duodenal tumors. For non‑ampulla duodenal tumors, partial duodenum resection and subtotal gastrectomy were appropriate for selection as methods of treatment. No survival benefits were identified for adjuvant chemotherapy. Duodenal tumors were shown to be a rare neoplasm with atypical symptoms; they should be diagnosed and treated as early as possible; CT and gastroscopy may be used for screening, radical surgery offers the best treatment; pancreatoduodenectomy is not the only surgery option available; and chemotherapy did not result in any survival benefits.
- 1 January 2016
- Published by Elsevier in The Spine Journal
- Vol. 16 (1) , 10-15
Cervical degenerative spondylolisthesis: analysis of facet orientation and the severity of cervical spondylolisthesis
- 1 January 2016
- Published by Elsevier in The Spine Journal
- Vol. 16 (1) , 10-15
Cervical degenerative spondylolisthesis: analysis of facet orientation and the severity of cervical spondylolisthesis
- Open Access
- 24 June 2015
- Published by Spandidos Publications in Oncology Letters
- Vol. 10 (3) , 1749-1754
Association between prognostic factors and clinical outcome of well-differentiated thyroid carcinoma: A retrospective 10-year follow-up study
Differentiated thyroid carcinoma (DTC) is one of the most common metabolic disorders and accounts for 98% of all cases of thyroid cancer. Previously, a number of studies have investigated the prognostic factors associated with well-differentiated thyroid carcinoma (WDTC); however, these studies yielded conflicting results. The current study used a retrospective study design to collect data from WDTC patients who had received the same treatment regimen from the same institute, with a minimum follow-up of 10 years. The De Groot staging system was used to classify WDTC in a total of 320 patients (240 females and 80 males). Among the subjects, the pathological subtypes identified were as follows: Papillary carcinoma (240 cases, 75%), follicular carcinoma (67 cases, 21%) and Hürthle cell carcinoma (13 cases, 4%). Prognostic factors that significantly affected the clinical outcome of the disease were advanced age (P=0.001), tumor size (P=0.03), presence of thyroglobulin (P=0.001) and De Groot stage (P=0.005). The 10-year follow-up study revealed that WDTC is associated with a high survival rate of 96% (307/320 patients survived) and a low mortality rate (4%).
- 24 June 2015
- Published by Spandidos Publications in Oncology Letters
- Vol. 10 (3) , 1749-1754
Open AccessAssociation between prognostic factors and clinical outcome of well-differentiated thyroid carcinoma: A retrospective 10-year follow-up study
Differentiated thyroid carcinoma (DTC) is one of the most common metabolic disorders and accounts for 98% of all cases of thyroid cancer. Previously, a number of studies have investigated the prognostic factors associated with well-differentiated thyroid carcinoma (WDTC); however, these studies yielded conflicting results. The current study used a retrospective study design to collect data from WDTC patients who had received the same treatment regimen from the same institute, with a minimum follow-up of 10 years. The De Groot staging system was used to classify WDTC in a total of 320 patients (240 females and 80 males). Among the subjects, the pathological subtypes identified were as follows: Papillary carcinoma (240 cases, 75%), follicular carcinoma (67 cases, 21%) and Hürthle cell carcinoma (13 cases, 4%). Prognostic factors that significantly affected the clinical outcome of the disease were advanced age (P=0.001), tumor size (P=0.03), presence of thyroglobulin (P=0.001) and De Groot stage (P=0.005). The 10-year follow-up study revealed that WDTC is associated with a high survival rate of 96% (307/320 patients survived) and a low mortality rate (4%).